Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure

References

• Allemann E, Doelker E, Gurny R. Drug loaded poly (lactic acid) nanoparticles produced by a reversible salting-out process: Purification of an injectable dosage form. European Journal of Pharmaceutics and Biopharmaceutics 1993; 39: 13–18
   Web of Science ®Google Scholar
• Allemann E, Gurny R, Doelker E. Preparation of aqueous polymeric nanodispersions by a reversible salting-out process, influence of process parameters on particles size. International Journal of Pharmaceutics 1992; 87: 247–253
   Web of Science ®Google Scholar
• Bilati U, Allemann E, Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. European Journal of Pharmaceutical Sciences 2005; 24: 67–75
   PubMed Web of Science ®Google Scholar
• Cegnar M, Kos J, Kristl J. Cystatin incorporated in poly(lactide-co-glycolide) nanoparticles: Development and fundamental studies on preservation of its activity. European Journal of Pharmaceutical Sciences 2004; 22: 357–364
   PubMed Web of Science ®Google Scholar
• Chorny M, Fishbein I, Danenberg HD, Golomb G. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: Effect of formulation variables on size, drug recovery and release kinetics. Journal of Controlled Release 2002; 83: 389–400
   PubMed Web of Science ®Google Scholar
• Damiani P, Bearzotti M, Cabezon MA. A validated spectrofluorometric method for the determination of celecoxib in capsules. Analytical and Bioanalytical Chemistry 2003; 376: 1141–1146
   PubMed Web of Science ®Google Scholar
• Delie F, Blanco-Prieto MJ. Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules 2005; 10: 65–80
   PubMed Web of Science ®Google Scholar
• Feng S, Huang G. Effects of emulsifiers on the controlled release of paclitaxel (Taxol®) from nanospheres of biodegradable polymers. Journal of Controlled Release 2001; 71: 53–69
   PubMed Web of Science ®Google Scholar
• Fessi H, Puisieux F, Devissaguet J Ph, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. International Journal of Pharmaceutics 1989; 55: R1–R4
   Web of Science ®Google Scholar
• Fonseca C, Simões S, Gaspar R. Paclitaxel-loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vitro anti-tumoral activity. Journal of Controlled Release 2002; 83: 273–286
   PubMed Web of Science ®Google Scholar
• Govender T, Stolnik S, Garnett MC, Illum L, Davis SS. PLGA nanoparticles prepared by nanoprecipitation: Drug loading and release studies of a water soluble drug. Journal of Controlled Release 1999; 57: 171–185
   PubMed Web of Science ®Google Scholar
• Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Current Opinion in Solid State and Materials Science 2002; 6: 319–327
   Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable PLGA devices. Biomaterials 2000; 21: 2475–2490
   PubMed Web of Science ®Google Scholar
• Jeon HJ, Jeong YI, Jang MK, Park YH, Nah JW. Effect of solvent on the preparation of surfactant-free poly(-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics. International Journal of Pharmaceutics 2000; 207: 99–108
   PubMed Web of Science ®Google Scholar
• Konan YN, Cerny R, Favet J, Berton M, Gurny R, Allemann E. Preparation and characterization of aterile sub-200 nm meso-tetra (4-hydroxylphenyl) porphoryin-loaded nanoparticles for photodynamic therapy. European Journal of Pharmaceutics and Biopharmaceutics 2003; 55: 115–124
   PubMed Web of Science ®Google Scholar
• Konan YN, Gurny R, Allemann E. Preparation and characterization of sterile and freeze-dried sub 200 nm nanoparticles. International Journal of Pharmaceutics 2002; 233: 239–252
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Yves Bouligand Y, Jean-Pierre Benoit JP. New lipid nanocapsules exhibit sustained release properties for amiodarone. Journal of Controlled Release 2002; 84: 59–68
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: Effect of formulation variables on size distribution. International Journal of Pharmaceutics 2005; 290: 137–144
   PubMed Web of Science ®Google Scholar
• Martínez-Sancho C, Herrero-Vanrell R, Negro S. Optimisation of aciclovir poly(-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study. International Journal of Pharmaceutics 2004; 273: 45–56
   PubMed Web of Science ®Google Scholar
• McCarron PA, Woolfson AD, Keating SM. Sustained release of 5-flurouracil from polymeric nanoparticles. Journal of Pharmacy and Pharmacology 2000; 52: 1451–1459
   PubMed Web of Science ®Google Scholar
• Murakami H, Kawashima Y, Niwa T, Hino T, Takeuchi H, Kobayashi M. Influence of degrees of hydrolyzation and polymerization of PVA on the preparation of PLGA nanoparticles. International Journal of Pharmaceutics 1997; 149: 43–49
   Web of Science ®Google Scholar
• Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of PLGA nanoparticles by modified spontaneous emulsification solvent diffusion method. International Journal of Pharmaceutics 1999; 187: 143–152
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly(lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. Journal of Controlled Release 2002; 82: 105–114
   PubMed Web of Science ®Google Scholar
• Scholes PD, Coombes AGA, Illum L, Davis SS, Vert M, Davies MC. The preparation of sub-200 nm poly(lactide-co-glycolide) microspheres for site-specific drug delivery. Journal of Controlled Release 1993; 25: 145–153
   Web of Science ®Google Scholar
• Seedher N, Bhatia S. Solubility enhancement of COX-2 inhibitors using various solvent systems. AAPS Parm Sci tech 2003; 4: 1–9
   Google Scholar
• Solaro R. Nanostructured polymeric systems in targeted release of proteic drugs and in tissue engineering. China-EU forum on Nanosized Technology, BeijingP.R., China 2002; 225–244
   Google Scholar
• Song CX, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebuski RJ, Levy RJ. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. Journal of Controlled Release 1997; 43: 197–212
   Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. Journal of Controlled Release 2001; 70: 1–20
   PubMed Web of Science ®Google Scholar
• Subramaian N, Ray S, Ghosal SK, Bhadra R, Moulik SP. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biological & Pharmaceutical Bulletin 2004; 27: 1993–1999
   PubMed Web of Science ®Google Scholar
• Teixeira M, Alonso MJ, Pinto MMM, Barbosa CM. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. European Journal of Pharmaceutics and Biopharmaceutics 2005; 59: 491–500
   PubMed Web of Science ®Google Scholar
• Ubrich N, Bouillot P, Pellerin C, Hoffman M, Maincent P. Preparation and characterization of propranolol hydrochloride nanoparticles: A comparative study. Journal of Controlled Release 2004; 97: 291–300
   PubMed Web of Science ®Google Scholar
• Vandervoort J, Ludwig A. Biocompatible stabilisers in the preparation of PLGA nanoparticles: A factorial design study. International Journal of Pharmaceutics 2002; 238: 77–92
   PubMed Web of Science ®Google Scholar
• Wang L, Chaw CS, Yang YY, Moochhala SM, Zhao B, Ng S, Heller J. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(-lactide-co-glycolide) blend microspheres fabricated by spray drying. Biomaterials 2004; 25: 3275–3282
   PubMed Web of Science ®Google Scholar
• Washington C. Drug release from microdisperse systems, a critical review. International Journal of Pharmaceutics 1990; 58: 1–12
   Web of Science ®Google Scholar
• Win KY, Feng SS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005; 26: 2713–2722
   PubMed Web of Science ®Google Scholar
• Zambaux MF, Bonneaux F, Gref R, Maincent P, Dellacherie E, Alonso MJ, Labrude P, Vigneron C. Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. Journal of Controlled Release 1998; 50: 31–40
   PubMed Web of Science ®Google Scholar